Literature DB >> 15546893

Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients.

Hae Hyuk Jung1, Kyung Ran Ma, Heon Han.   

Abstract

BACKGROUND: Elevated concentrations of cardiac biomarkers, such as troponins and natriuretic peptides, have been shown to be predictive of poorer long-term cardiovascular outcomes in stable patients with end-stage renal disease (ESRD). However, little is known about the relationship between elevated concentrations of these cardiac markers and underlying coronary artery pathology in these patients. The aim of the present study was to investigate associations between coronary artery calcification (CAC) and the concentrations of cardiac biomarkers in ESRD patients.
METHODS: We conducted a cross-sectional study of 38 asymptomatic patients (median age, 54 years; 26 males, 12 females; diabetic, 39%) who were undergoing chronic haemodialysis. In these patients, pre-dialysis circulating concentrations of cardiac troponin T (cTnT), cardiac troponin I (cTnI), creatine kinase-MB (CK-MB) and B-type natriuretic peptide (BNP) were measured. We quantified the level of CAC by multirow spiral computed tomography to obtain a CAC score. CAC scores > or = 400 were defined as being indicative of severe CAC.
RESULTS: Severe CAC was detected in 17 patients (45%). The degree of CAC severity was positively associated (P < 0.05) with cTnT concentrations. Thus, 15% of patients had severe CAC in the lowest tertile of cTnT, 50% had severe CAC in the middle third, and 69% in the highest third. Similarly, the degree of severity of CAC was positively associated (P < 0.01) with cTnI concentrations across concentration categories. In contrast, there was no association between the degree of CAC severity and the concentrations of either BNP or CK-MB. A logistic regression analysis revealed that elevated concentrations of cTnT (> or = median vs <median, P < 0.05) and cTnI (> or = 0.1 ng/ml vs <detection limit, P < 0.05) were independently associated with severe CAC after adjusting for age, duration of dialysis, diabetes and previous cardiovascular events.
CONCLUSIONS: Elevated concentrations of cTnT and cTnI, but not BNP or CK-MB, were independently associated with the degree of severity of CAC in asymptomatic haemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546893     DOI: 10.1093/ndt/gfh488

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  A review of troponins in ischemic heart disease and other conditions.

Authors:  Nedaa Skeik; Deevia Chandrakant Patel
Journal:  Int J Angiol       Date:  2007

Review 2.  Cardiac enzymes, renal failure and renal transplantation.

Authors:  Huseyin Bozbas; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Clin Med Res       Date:  2006-03

Review 3.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

4.  Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients.

Authors:  Kamal M Okasha; Mohamed Hussein Aboufreikha; Waleed Elrefaey; Medhat M Ashmawy; Heba Mourad; Mohamed A Elsebaey; Mohammed H Elnaggar; Raghda Gabr Mashaal; Sama Metwally; Shaimaa Samir Amin Mashal; Neveen A Shalaby; Shireen Ali Elhoseny; Amr Alkassas; Mohammed Elbarbary; Osama Shoeib; Dina A Ali; Nivin Baiomy; Sherein M Alnabawy
Journal:  Front Med (Lausanne)       Date:  2022-06-22

5.  Biomarkers in predicting mortality and treatment in hemodialysis patients.

Authors:  Angela Yee-Moon Wang
Journal:  F1000 Med Rep       Date:  2009-03-17

6.  Plasma alkaline phosphatase and survival in diabetic patients with acute myocardial infarction.

Authors:  José Pedro L Nunes; Filipa Melão; Ana Rita Godinho; Joana D Rodrigues; Maria Júlia Maciel
Journal:  Ann Transl Med       Date:  2016-06

7.  A more appropriate cardiac troponin T level that can predict outcomes in end-stage renal disease patients with acute coronary syndrome.

Authors:  Dong-Ryeol Ryu; Jung Tak Park; Jung Hwa Chung; Eun Mi Song; Sun Hee Roh; Jeong-Min Lee; Hye Rim An; Mina Yu; Wook Bum Pyun; Gil Ja Shin; Seung-Jung Kim; Duk-Hee Kang; Kyu Bok Choi
Journal:  Yonsei Med J       Date:  2011-07       Impact factor: 2.759

8.  Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality.

Authors:  Ferruh Artunc; Christian Mueller; Tobias Breidthardt; Raphael Twerenbold; Andreas Peter; Claus Thamer; Peter Weyrich; Hans-Ulrich Haering; Bjoern Friedrich
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.

Authors:  Maurits S Buiten; Mihály K de Bie; Joris I Rotmans; Friedo W Dekker; Marjolijn van Buren; Ton J Rabelink; Christa M Cobbaert; Martin J Schalij; Arnoud van der Laarse; J Wouter Jukema
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

10.  In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter.

Authors:  Theodor Baars; Ursula Neumann; Mona Jinawy; Stefanie Hendricks; Jan-Peter Sowa; Julia Kälsch; Mona Riemenschneider; Guido Gerken; Raimund Erbel; Dominik Heider; Ali Canbay
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.